Company / PP&E per Share
CAPRICOR THERAPEUTICS, INC. PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.32
FY2025
5-year range
$0.07 / $0.32
FY2021-FY2025
Trend
+161.6%
vs FY2024
Sector context
#68 of 193
Health Care
What the data says
At $0.32, CAPRICOR THERAPEUTICS, INC.'s pp&e per share ranks #68 of 193 in the Health Care sector. PP&E per Share returned to growth in FY2025 after 2 years of decline, reaching $0.32.
Based on SEC 10-K filings.
0.32 in FY2025 with a 5-year CAGR of +50.5%.
Improved from $0.18 to $0.32 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +20.6%
- 5-Year CAGR
- +50.5%
- 10-Year CAGR
- -
Sector benchmark
#68 of 193 in Health CareTop 35% of 193This company $0.32 Sector average $22.13
▼
-98.6% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share increased 161.6% year-over-year.
- Ranks #68 out of 193 companies in the Health Care sector.
- Lowest pp&e per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.32 | +161.6% |
| FY2024 | $0.12 | -31.7% |
| FY2023 | $0.18 | -1.8% |
| FY2022 | $0.18 | +144.8% |
| FY2021 | $0.07 | +79.6% |
| FY2020 | $0.04 | -70.7% |
| FY2019 | $0.14 | +671.2% |
| FY2018 | $0.02 | +29.2% |
| FY2017 | $0.01 | -30.4% |
| FY2016 | $0.02 | +3.8% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026